Profarma Distribuidora (Brazil) Insiders
| PFRM3 Stock | BRL 6.27 0.17 2.79% |
Profarma Distribuidora employs about 7.1 K people. The company is managed by 7 executives with a total tenure of roughly 95 years, averaging almost 13.0 years of service per executive, having 1011.0 employees per reported executive. Breaking down Profarma Distribuidora's management performance can provide insight into the firm performance.
| Sammy Birmarcker Chairman CEO, Member of the Executive Board, Chairman of the Board |
| Manoel Birmarcker Chairman Vice Chairman of the Board |
Profarma |
Profarma Distribuidora Management Team Effectiveness
The company has return on total asset (ROA) of 0.0368 % which means that it generated a profit of $0.0368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0645 %, meaning that it generated $0.0645 on every $100 dollars invested by stockholders. Profarma Distribuidora's management efficiency ratios could be used to measure how well Profarma Distribuidora manages its routine affairs as well as how well it operates its assets and liabilities.Profarma Distribuidora Workforce Comparison
Profarma Distribuidora de is considered to be number one stock in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 68,399. Profarma Distribuidora retains roughly 7,077 in number of employees claiming about 10% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.03 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.03. Profarma Distribuidora Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Profarma Distribuidora Price Series Summation is a cross summation of Profarma Distribuidora price series and its benchmark/peer.
Profarma Distribuidora Notable Stakeholders
A Profarma Distribuidora stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Profarma Distribuidora often face trade-offs trying to please all of them. Profarma Distribuidora's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Profarma Distribuidora's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Sammy Birmarcker | CEO, Member of the Executive Board, Chairman of the Board | Profile | |
| Manoel Birmarcker | Vice Chairman of the Board | Profile | |
| Armando Martins | Director | Profile | |
| Fernando Perrone | Independent Director | Profile | |
| Maximiliano Fischer | CFO, Director of Investor Relations, Member of the Executive Board | Profile | |
| Dan Ioschpe | Independent Director | Profile | |
| Adriano Prado | Member Officers | Profile |
About Profarma Distribuidora Management Performance
The success or failure of an entity such as Profarma Distribuidora often depends on how effective the management is. Profarma Distribuidora management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Profarma management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Profarma management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Profarma Distrib Prod Farmaceuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical and hospital products in Brazil. The company was founded in 1961 and is headquartered in Rio de Janeiro, Brazil. PROFARMA operates under Medical Distribution classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 6327 people.
The data published in Profarma Distribuidora's official financial statements usually reflect Profarma Distribuidora's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Profarma Distribuidora. For example, before you start analyzing numbers published by Profarma accountants, it's critical to develop an understanding of what Profarma Distribuidora's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Profarma Distribuidora's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Profarma Distribuidora's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Profarma Distribuidora's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Profarma Distribuidora de. Please utilize our Beneish M Score to check the likelihood of Profarma Distribuidora's management manipulating its earnings.
Profarma Distribuidora Workforce Analysis
Traditionally, organizations such as Profarma Distribuidora use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Profarma Distribuidora within its industry.Profarma Distribuidora Manpower Efficiency
Return on Profarma Distribuidora Manpower
| Revenue Per Employee | 906.2K | |
| Revenue Per Executive | 916.2M | |
| Net Income Per Employee | 11K | |
| Net Income Per Executive | 11.2M | |
| Working Capital Per Employee | 86.9K | |
| Working Capital Per Executive | 87.9M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profarma Distribuidora de. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Profarma Distribuidora information on this page should be used as a complementary analysis to other Profarma Distribuidora's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Profarma Stock analysis
When running Profarma Distribuidora's price analysis, check to measure Profarma Distribuidora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profarma Distribuidora is operating at the current time. Most of Profarma Distribuidora's value examination focuses on studying past and present price action to predict the probability of Profarma Distribuidora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profarma Distribuidora's price. Additionally, you may evaluate how the addition of Profarma Distribuidora to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |